Form 4: Marvell CFO's Routine Stock Vesting & Tax Withholding

Sentiment:

Insider Transaction Report


Marvell Technology's CFO, Willem A Meintjes, reported the vesting of Restricted Stock Units and subsequent share disposals for tax obligations on October 15, 2025.

Summary

  • Willem A Meintjes, Chief Financial Officer of Marvell Technology, Inc. (MRVL), reported transactions on October 15, 2025.
  • A total of 12,363 shares of common stock were acquired through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.
  • Concurrently, 5,156 shares were disposed of at a price of $88.89 per share to cover tax withholding obligations related to the RSU vesting.
  • Following these transactions, Meintjes' direct beneficial ownership of common stock increased from an initial reported 134,710 shares to 139,366 shares.
  • Remaining Restricted Stock Units (RSUs) totaling 63,974 are scheduled to vest on various dates through April 15, 2028.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation, specifically the vesting of Restricted Stock Units and subsequent tax withholding. These are standard, pre-scheduled events and do not indicate any significant positive or negative operational or financial developments for the company.

Positives

  • CFO Willem A Meintjes increased his direct beneficial ownership of Marvell Technology common stock by 4,656 shares, from 134,710 to 139,366, indicating continued alignment with shareholder interests.
  • The vesting of Restricted Stock Units represents a planned component of executive compensation, reflecting performance and retention incentives.

Negatives

  • A portion of the vested shares, specifically 5,156 shares, were sold to cover tax liabilities, which is a common practice but reduces the immediate increase in direct ownership.

Future Outlook

Remaining Restricted Stock Units totaling 63,974 are scheduled to vest in installments on January 15, 2026, April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028, and April 15, 2028.

Industry Context

This filing details routine executive compensation events specific to Marvell Technology's Chief Financial Officer and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: Minor, as it reflects routine executive compensation and a slight increase in insider ownership, aligning management interests with shareholders.
  • Employees: Reflects standard equity compensation practices for executives.

Next Steps

  • Future vesting of remaining Restricted Stock Units on various dates through April 15, 2028.

Key Dates

DateDescription
10/15/2025Date of RSU vesting and related stock transactions
01/15/2026Vesting date for remaining Restricted Stock Units
04/15/2026Vesting date for remaining Restricted Stock Units
07/15/2026Vesting date for remaining Restricted Stock Units
10/15/2026Vesting date for remaining Restricted Stock Units
01/15/2027Vesting date for remaining Restricted Stock Units
04/15/2027Vesting date for remaining Restricted Stock Units
07/15/2027Vesting date for remaining Restricted Stock Units
10/15/2027Vesting date for remaining Restricted Stock Units
01/15/2028Vesting date for remaining Restricted Stock Units
04/15/2028Vesting date for remaining Restricted Stock Units
10/16/2025Signature date of the reporting person

Keywords

Marvell Technology, MRVL, Willem A Meintjes, CFO, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Compensation, Tax Withholding, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.